Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

T2R42 Inhibitors

Chemical inhibitors of T2R42 include a diverse group of compounds that interact with the receptor to prevent the perception of bitterness. Denatonium Benzoate, known for its intense bitterness, can inhibit T2R42 by altering the receptor's conformation, effectively blocking its activation by other bitter compounds. Similarly, Quinine, a naturally occurring alkaloid, binds directly to the bitter taste receptor sites, which can obstruct the receptor's function. Naringin, a flavonoid prevalent in grapefruits, competitively binds to the active sites of T2R42, hindering activation by natural bitter ligands. Absinthin, another bitter substance, likely engages in negative allosteric modulation by binding to the receptor with high affinity, diminishing its ability to bind other bitter molecules.

Continuing the exploration of T2R42 inhibitors, Propylthiouracil (PTU) uses competitive inhibition, where it contends with other bitter ligands for the receptor's binding sites, thus preventing receptor activation. Parthenolide binds to the active sites of T2R42, inhibiting the receptor's response to bitterness. Amorolfine may alter the conformation of T2R42, reducing its interaction with bitter ligands. Similarly, Columbin and Amarogentin, both known for their bitterness, can inhibit T2R42 by binding with an affinity that surpasses other bitter molecules, thereby preventing receptor activation. Antibiotics like Erythromycin and Chloramphenicol interact with T2R42's active sites, leading to changes that inhibit the receptor's normal function. Lastly, Strychnine, a bitter and toxic alkaloid, inhibits T2R42 through competitive binding, which blocks the reception of bitter taste stimuli.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Denatonium benzoate

3734-33-6sc-234525
sc-234525A
sc-234525B
sc-234525C
sc-234525D
1 g
5 g
25 g
100 g
250 g
$32.00
$47.00
$141.00
$473.00
$921.00
(1)

Denatonium Benzoate is known as one of the most bitter substances and can inhibit T2R42 by binding to the bitter taste receptor, leading to a change in the receptor's conformation and preventing its activation by other bitter compounds that would typically trigger a bitter taste response.

Quinine

130-95-0sc-212616
sc-212616A
sc-212616B
sc-212616C
sc-212616D
1 g
5 g
10 g
25 g
50 g
$79.00
$104.00
$166.00
$354.00
$572.00
1
(0)

Quinine is an alkaloid that can act as an inhibitor of T2R42 by directly binding to the bitter taste receptor sites, which can block the receptor's function and prevent its activation by other bitter substances.

Naringin

10236-47-2sc-203443
sc-203443A
25 g
50 g
$45.00
$101.00
7
(1)

Naringin, a flavonoid found in grapefruits, possesses the capability to inhibit T2R42 by competitively binding to the receptor's active sites, thus hindering the receptor's activation by its natural bitter ligands.

6-Propyl-2-thiouracil

51-52-5sc-214383
sc-214383A
sc-214383B
sc-214383C
10 g
25 g
100 g
1 kg
$37.00
$56.00
$224.00
$1997.00
(0)

Propylthiouracil, known for its bitter taste, can inhibit T2R42 through competitive inhibition, where it competes with other bitter ligands for the receptor's binding sites, thereby preventing receptor activation.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$81.00
$306.00
32
(2)

Parthenolide, a sesquiterpene lactone from feverfew, can inhibit T2R42 by binding to the receptor's active sites. This interaction can prevent the receptor's normal response to bitter compounds, inhibiting its functional activity.

Erythromycin

114-07-8sc-204742
sc-204742A
sc-204742B
sc-204742C
5 g
25 g
100 g
1 kg
$57.00
$245.00
$831.00
$1331.00
4
(3)

Erythromycin, an antibiotic that has a bitter taste, can inhibit T2R42 by directly interacting with the receptor, potentially leading to changes in the receptor's structure that prevent activation by other bitter substances.

Chloramphenicol

56-75-7sc-3594
25 g
$90.00
10
(1)

Chloramphenicol, another antibiotic with a bitter component, can inhibit T2R42 by binding to the receptor's active sites, which can lead to an inhibition of the receptor's ability to be activated by bitter compounds.